Results for "Vision Problems"
Conditions Encyclopedia Entry 1779373564
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific type of disorder and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, rather than an inherited one. Diagnosis of MM typically involves a combination of genetic testing, muscle biopsy, and other medical tests. Treatment for MM is often focused on managing symptoms and improving quality of life, as there is currently no cure for the disorder. ### History/Background The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of MM was discovered. In 1988, a team of researchers identified the first mitochondrial DNA mutation associated with a myopathic disorder. Since then, numerous other mutations have been identified, and our understanding of the genetic basis of MM has continued to grow. ### Key Information Mitochondrial Myopathies are a heterogeneous group of disorders, with over 150 different mutations identified to date. The most common types of MM include: * **Kearns-Sayre Syndrome**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), muscle weakness, and cardiac conduction abnormalities. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy. * **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ### Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. While the disorders are rare, they can have a profound impact on the quality of life for those affected. Research into MM has also led to a greater understanding of the role of mitochondria in energy production and the development of new treatments for other disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions), 1988 (identification of first mitochondrial DNA mutation) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Rare Diseases, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Pain, Vision Problems, Hearing Loss, Balance Disorders, Autosomal Dominant Inheritance, Maternal Inheritance, New Mutation, Genetic Testing, Muscle Biopsy, Symptom Management, Quality of Life.
Health & MedicineConditions Encyclopedia Entry 1778756960
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare, inherited disorders that affect the mitochondria, the powerhouses of cells. These disorders are caused by mutations in mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including muscles, the nervous system, and other organs. Symptoms can vary widely among individuals, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are often inherited in a maternal lineage, meaning that they are passed down from mother to child. This is because only egg cells contribute mitochondria to the fertilized egg, while sperm cells do not. As a result, mitochondrial DNA is inherited solely from the mother. The disorders can be caused by mutations in any of the 37 genes found in mitochondrial DNA, which are responsible for encoding proteins involved in energy production. ## History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist named Keith Killen described a family with a rare disorder affecting the muscles and nervous system. However, it wasn't until the 1980s that the genetic basis of the disorder was identified. In 1988, a team of researchers led by Douglas C. Wallace discovered that the disorder was caused by a mutation in mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: - **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), which is a weakness of the eye muscles. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by seizures and muscle weakness. - **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. - **Leigh Syndrome**: a disorder characterized by progressive brain damage and muscle weakness. Symptoms of mitochondrial myopathies can vary widely among individuals, but often include: - Muscle weakness and fatigue - Pain and stiffness in the muscles - Difficulty walking or maintaining balance - Seizures and epilepsy - Vision problems, including blindness - Hearing loss - Cognitive impairment and dementia ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on affected individuals and families. While there is currently no cure for these disorders, researchers are working to develop new treatments, including gene therapy and mitochondrial-targeted antioxidants. Understanding the genetic basis of mitochondrial myopathies has also led to a greater appreciation of the importance of mitochondria in human health and disease. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1962 (first reported case) - Location: Worldwide - Known For: Rare inherited disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Inherited Disorders, Muscle Weakness, Fatigue, Pain, Seizures, Epilepsy, Vision Problems, Hearing Loss, Cognitive Impairment.
Health & MedicineConditions Encyclopedia Entry 1777998620
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders occur when there are mutations in the mitochondrial DNA, which codes for proteins essential for energy production. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and difficulty with physical activities. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a mutation in one copy of the mitochondrial DNA is enough to cause the disorder. This is because only egg cells contribute mitochondria to the fertilized egg, making mitochondrial DNA inherited solely from the mother. The disorders can also occur spontaneously, without a family history. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to understand the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of mitochondrial DNA mutations led to a greater understanding of the underlying causes of these disorders and paved the way for diagnostic testing. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: - **Muscle weakness**: Muscle weakness is a common symptom of mitochondrial myopathies, particularly in the muscles of the face, arms, and legs. - **Fatigue**: Fatigue is another common symptom, which can be debilitating and affect daily activities. - **Difficulty with physical activities**: Patients with mitochondrial myopathies may experience difficulty with physical activities, such as walking or climbing stairs. - **Vision problems**: Some patients may experience vision problems, including blurred vision or loss of vision. - **Cognitive impairment**: Cognitive impairment, including memory loss and difficulty with concentration, can occur in some patients. There are several types of mitochondrial myopathies, including: - **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: This is a severe form of mitochondrial myopathy that affects the brain, muscles, and other organs. - **Myoclonic epilepsy with ragged-red fibers (MERRF)**: This disorder affects the muscles and nervous system, causing muscle weakness, seizures, and other symptoms. - **Kearns-Sayre syndrome**: This disorder affects the muscles, nervous system, and other organs, causing muscle weakness, vision problems, and other symptoms. ## Significance Mitochondrial myopathies are rare disorders that affect a small number of people worldwide. However, they have significant implications for patients and families affected by these disorders. The diagnosis of mitochondrial myopathies can be challenging, and it often requires a combination of clinical evaluation, genetic testing, and other diagnostic tests. The significance of mitochondrial myopathies lies in their impact on patients and families. These disorders can have a profound effect on quality of life, causing significant disability and affecting daily activities. However, with advances in diagnostic testing and treatment, patients with mitochondrial myopathies can receive more effective care and management. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Energy Production, Mitochondrial DNA, Autosomal Dominant, Maternal Inheritance, Muscle Weakness, Fatigue, Vision Problems, Cognitive Impairment, Rare Disorders.
Health & MedicineConditions Encyclopedia Entry 1782907685
** This encyclopedia entry provides a comprehensive overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the muscles and energy production within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of inherited disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. MMs are characterized by their unique inheritance pattern, where the mutated gene is passed down from mother to child. This is because only egg cells contribute mitochondria to the developing embryo, making the disorder more prevalent in females. Mitochondrial Myopathies can manifest in various forms, including **Kearns-Sayre Syndrome**, **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, and **Chronic Progressive External Ophthalmoplegia (CPEO)**. Each form has distinct clinical features, but they all share a common underlying cause: the disruption of normal mitochondrial function. The symptoms of MMs can vary widely, ranging from mild to severe, and may include muscle weakness, exercise intolerance, seizures, and vision problems. ## History/Background The first reported case of a mitochondrial myopathy dates back to 1957, when a British physician, **John Walton**, described a patient with a rare muscle disorder. However, it wasn't until the 1960s that the concept of mitochondrial inheritance began to take shape. The discovery of mitochondrial DNA in 1964 by **Barbara McClintock** and **John Cairns** laid the groundwork for understanding the genetic basis of MMs. In the 1980s, the first mitochondrial myopathy was identified as a distinct clinical entity, and since then, numerous studies have shed light on the molecular mechanisms underlying these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is responsible for encoding genes involved in energy production. The most common mutations associated with MMs are point mutations, deletions, or duplications in the mitochondrial genome. These genetic alterations disrupt the normal functioning of the mitochondria, leading to a decrease in energy production and an accumulation of toxic byproducts. The symptoms of MMs can be managed through a combination of lifestyle modifications, medication, and physical therapy. Some key facts about Mitochondrial Myopathies include: * **Inheritance pattern**: MMs are inherited in a maternal lineage, meaning the mutated gene is passed down from mother to child. * **Prevalence**: MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Symptoms**: Muscle weakness, fatigue, seizures, vision problems, and exercise intolerance are common symptoms of MMs. * **Treatment**: There is no cure for MMs, but symptoms can be managed through a combination of lifestyle modifications, medication, and physical therapy. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of understanding the genetic basis of human disease. The study of MMs has led to important advances in our understanding of mitochondrial function and the development of new treatments for related disorders. Furthermore, MMs serve as a reminder of the complex interplay between genetic and environmental factors that contribute to human disease. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First reported case in 1957 - **Location:** Worldwide - **Known For:** Unique inheritance pattern and disruption of mitochondrial function ## Tags: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Chronic Progressive External Ophthalmoplegia, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Seizures, Vision Problems, Exercise Intolerance, Genetic Disorders, Rare Diseases, Inherited Disorders, Maternal Lineage.
Health & MedicineConditions Encyclopedia Entry 1780609884
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which are responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of MM can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial Myopathies are a complex and heterogeneous group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include Kearns-Sayre Syndrome (KSS), Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these forms has distinct clinical features and prognoses. The diagnosis of Mitochondrial Myopathies is often challenging, as the symptoms can be nonspecific and overlap with other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### History/Background The first reported case of Mitochondrial Myopathy was in 1957, when a 12-year-old boy was described with a rare condition characterized by progressive external ophthalmoplegia and muscle weakness. However, it wasn't until the 1960s and 1970s that the mitochondrial DNA was identified as the source of the mutations causing these disorders. In the 1980s, the first molecular genetic studies were conducted on Mitochondrial Myopathies, leading to the identification of several key mutations. The development of genetic testing and muscle biopsy techniques has greatly improved the diagnosis and management of MM. ### Key Information **Key Facts:** - **Prevalence:** Mitochondrial Myopathies are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people. - **Inheritance:** MM can be inherited in an autosomal dominant, autosomal recessive, or mitochondrial pattern. - **Symptoms:** Muscle weakness, fatigue, seizures, vision problems, and other systemic symptoms. - **Prognosis:** The prognosis varies depending on the specific form of MM, but most patients experience a gradual decline in function over time. **Key Achievements:** - **Genetic testing:** The development of genetic testing has greatly improved the diagnosis of MM. - **Muscle biopsy:** Muscle biopsy has become a crucial tool in the diagnosis and management of MM. - **Clinical trials:** Several clinical trials have been conducted to investigate the effectiveness of various treatments for MM. ### Significance Mitochondrial Myopathies are a significant public health concern, as they can have a profound impact on the quality of life of affected individuals and their families. The diagnosis and management of MM require a multidisciplinary approach, involving geneticists, neurologists, and other specialists. The study of Mitochondrial Myopathies has also led to a greater understanding of the role of mitochondria in human disease and has implications for the treatment of other conditions, such as neurodegenerative diseases and cancer. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1957 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Seizures, Vision Problems, Genetic Testing, Muscle Biopsy, Clinical Trials, Multidisciplinary Approach.